Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Estrogens, conjugated synthetic b - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for estrogens, conjugated synthetic b?

Estrogens, conjugated synthetic b is the generic ingredient in one branded drug marketed by Teva Womens and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has seventeen patent family members in nine countries.

There are three drug master file entries for estrogens, conjugated synthetic b. Two suppliers are listed for this compound.

Summary for Generic Name: estrogens, conjugated synthetic b

Tradenames:1
Patents:2
Applicants:1
NDAs:1
Drug Master File Entries: see list3
Suppliers / Packagers: see list2
Clinical Trials: see list369
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:estrogens, conjugated synthetic b at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Womens
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-002Dec 20, 2004RXNoNo6,855,703► SubscribeYY ► Subscribe
Teva Womens
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-004May 10, 2004DISCNNoNo6,855,703► SubscribeYY ► Subscribe
Teva Womens
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-005Apr 27, 2007RXNoNo6,660,726► SubscribeYY ► Subscribe
Teva Womens
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-003May 10, 2004DISCNNoNo6,855,703► SubscribeYY ► Subscribe
Teva Womens
ENJUVIA
estrogens, conjugated synthetic b
TABLET;ORAL021443-001Dec 20, 2004RXNoNo6,660,726► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: estrogens, conjugated synthetic b

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,227,454Estrogenic compounds, pharmaceutical compositions and formulations comprising the same► Subscribe
7,179,799(3) and (6) substituted estrogenic compounds► Subscribe
6,844,334 (3) and (6) substitued estrogenic compounds► Subscribe
6,250,127 Heat-dissipating aluminum silicon carbide composite manufacturing method► Subscribe
7,459,445Estrogenic compounds and topical pharmaceutical formulations of the same► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: estrogens, conjugated synthetic b

Country Document Number Estimated Expiration
European Patent Office1263770► Subscribe
Australia4733701► Subscribe
Australia2001245417► Subscribe
MexicoPA02008856► Subscribe
South Korea20070045364► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc